產品編號
1300314
CAS 號
1162-56-7
中文名稱
(8S,9S,10R,13S,14S,17S)-17-乙酰基-10,13-二甲基-8,9,10,11,12,13,14,15,16,17-十氫-1H-環戊二烯并[a]菲-3(2H)-酮(地屈孕酮雜質)
MDL 號
MFCD00199858
分子量
312.45
存儲條件
網頁展示純度為入庫指導純度值,各批次間存在一定差異,實際純度以收貨為準
熔點
147-148 °C
沸點
462.8±45.0 °C at 760 mmHg
閃點
旋光
描述
TPSA
34.14
LogP
4.4995
H_Acceptors
2
H_Donors
0
Rotatable_Bonds
1
[1]. Agnieszka Rajtar-Ciosek, et al. Beneficial influence of postmenopausal estrogen therapy on serum adhesion molecules is independent of the route and dose of administration. Neuro Endocrinol Lett. 2011;32(3):340-4.
[2]. Daisuke Akashi, et al. Successful use of dydrogesterone as maintenance therapy in recurrent endometrial stromal sarcoma: a case report. Jpn J Clin Oncol. 2013 Nov;43(11):1145-9.
[3]. Ireneusz Po?a?, et al. Coagulation and fibrynolitic parameters in women and the effects of hormone therapy; comparison of transdermal and oral administration. Gynecol Endocrinol. 2013 Feb;29(2):165-8.
[4]. John C Stevenson, et al. Oral estradiol and dydrogesterone combination therapy in postmenopausal women: review of efficacy and safety. Maturitas. 2013 Sep;76(1):10-21.
[5]. Julia Maria Naumann, et al. Biotechnological production of 20-alpha-dihydrodydrogesterone at pilot scale. Appl Biochem Biotechnol. 2011 Sep;165(1):190-203.
警示圖
警示詞
Warning
危險申明
H302-H315-H319-H335
警告申明
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P405-P501
GHS 編碼
GHS07
展開更多
現貨供應
專業護航
售后無憂
品質保障
無需湊單